Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 13, 2018
- Source ID
- 10.1371/journal.pone.0198790
Entities
People
- Frances Greathouse
- Jessica F. Olive
- Molly J. Decristo
- Sandra S McAllister
- Tyler Laszewski
- Yuanbo Qin
Organizations
- Foundation for the National Institutes of Health
- United States Department of Defense